Avidity Partners Management LP Baxter International Inc Transaction History

Avidity Partners Management LP

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$39.98 - $47.68 $24.2 Million - $28.8 Million	604,700 New	604,700 $27.6 Million
Q2 2022 Aug 15, 2022	SELL	$63.83 - $80.0 $122 Million - $153 Million	-1,915,500 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$76.85 - $89.45 $11.6 Million - $13.5 Million	150,500 Added 8.53%	1,915,500 $149 Million
Q4 2021 Feb 14, 2022	BUY	$74.57 - $87.19 $67.3 Million - $78.7 Million	903,000 Added 104.76%	1,765,000 $152 Million
Q3 2021 Nov 15, 2021	BUY	$73.77 - $83.61 $63.6 Million - $72.1 Million	862,000 New	862,000 $69.3 Million
Q4 2020 Feb 16, 2021	SELL	$75.39 - $82.36 $46.7 Million - $51.1 Million	-620,000 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$78.33 - $90.73 $14.2 Million - $16.4 Million	-180,900 Reduced 22.59%	620,000 $49.9 Million
Q2 2020 Aug 14, 2020	BUY	$78.66 - $94.14 $63 Million - $75.4 Million	800,900 New	800,900 $69 Million
Q1 2020 May 15, 2020	SELL	$71.57 - $93.3 $11.8 Million - $15.4 Million	-165,000 Closed	0 $0
Q4 2019 Jun 17, 2020	BUY	$76.7 - $88.45 $12.7 Million - $14.6 Million	165,000 New	165,000 $13.8 Million

981

446M

2.22M

3.04M

Ticker BAX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 504,120,992
Market Cap $19.8B
Description
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...

Get notified when there are updates to the investment portfolio of Avidity Partners Management LP, based on Form 13F filings with the SEC.

Stay updated on Avidity Partners Management LP with notifications on news.